Literature DB >> 23538154

Influence of transradial versus transfemoral diagnostic heart catheterisation on peripheral vascular endothelial function.

Luigi Di Serafino1, Stylianos A Pyxaras, Fabio Mangiacapra, Karen Dierickx, Gabor Toth, Jozef Bartunek, Bernard De Bruyne, Carlos Van Mieghem, William Wijns, Emanuele Barbato.   

Abstract

AIMS: Endothelium dysfunction has been reported in patients (pts) undergoing transradial catheterisation. Alterations of the hand microcirculation possibly associated with systemic inflammation have never previously been reported. We aimed at investigating possible alteration of hand endothelial microcirculation secondary to transradial heart catheterisation. METHODS AND
RESULTS: We randomised 40 pts with stable angina undergoing coronary angiography to either transradial (TR, n=20) or transfemoral (TF, n=20) approach. At baseline (BL), 24 hours (24 hrs) and 30 days (FU: follow-up) after catheterisation we assessed: a) peripheral endothelial function (EndoScore [ES]) by peripheral arterial tonometry (EndoPAT); b) biomarkers of endothelial turnover (sE-Selectin) and inflammation (hs-CRP). No clinical or angiographic differences were observed between the two groups. At 24 hours, ES (BL: 0.42±0.27 vs. 24 hours: 0.27±0.19, p<0.05) significantly decreased in the TR group, but not in the TF group (BL: 0.44±0.34 vs. 24 hours: 0.45±0.39, n.s.). Both sE-Selectin and hs-CRP increased significantly at 24 hours in all pts. At 30 days, we observed in the TR group a restoration of ES (FU: 0.44±0.34, n.s. vs. BL; p<0.05 vs. 24 hours), while no difference was observed in the TF group. A reduction towards baseline was observed in both groups of sE-Selectin and hs-CRP.
CONCLUSIONS: A transient impairment of the digital microcirculatory endothelial function is observed in patients undergoing transradial diagnostic catheterisation, beyond local mechanical injury at the arterial access and on top of the systemic inflammatory response associated with heart catheterisation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23538154     DOI: 10.4244/EIJV8I11A193

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  3 in total

1.  Double-blind parallel placebo-controlled study to evaluate the effect of molsidomine on the endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: the MEDCOR Trial.

Authors:  Emanuele Barbato; Arnold Herman; Edouard Benit; Luc Janssens; Jacques Lalmand; Etienne Hoffer; Patrick Chenu; Antoine Guédès; Luc Missault; Bruno Pirenne; François Cardinal; Steven Vercauteren; William Wijns
Journal:  J Cardiovasc Transl Res       Date:  2013-10-19       Impact factor: 4.132

2.  Extremity Dysfunction After Large-Bore Radial and Femoral Arterial Access.

Authors:  Thomas A Meijers; Adel Aminian; Marleen van Wely; Koen Teeuwen; Thomas Schmitz; Maurits T Dirksen; Sudhir Rathore; René J van der Schaaf; Paul Knaapen; Joseph Dens; Juan F Iglesias; Pierfrancesco Agostoni; Vincent Roolvink; Miguel E Lemmert; Renicus S Hermanides; Niels van Royen; Maarten A H van Leeuwen
Journal:  J Am Heart Assoc       Date:  2022-01-13       Impact factor: 6.106

3.  Evolution of blood biomarker levels following percutaneous atrial septal defect closure in adults.

Authors:  Laurie W Geenen; Lucas Uchoa de Assis; Vivan J M Baggen; Jannet A Eindhoven; Judith A A E Cuypers; Eric Boersma; Jolien W Roos-Hesselink; Annemien E van den Bosch
Journal:  Int J Cardiol Heart Vasc       Date:  2020-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.